XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Equity-based Compensation
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Equity-based Compensation
(8)
Equity‑based Compensation

On January 1, 2022, the number of shares of common stock available for issuance under the 2015 Equity Incentive Award Plan (the “2015 Plan”) and the 2015 Employee Stock Purchase Plan (“ESPP”) was increased by 3,484,942 shares and 696,988 shares, respectively, due to the annual evergreen provision to increase shares available under the 2015 Plan and the ESPP. As of June 30, 2022, there were an aggregate of 2,259,432 shares available for future grant under the 2017 Stock Incentive Plan (the 2017 Plan) and the 2015 Plan, and 1,341,339 shares available for future grant under the ESPP.

The following table summarizes equity‑based compensation expense within the Company’s consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2022 and 2021 (in thousands):

 

 

 

Three Months Ended June 30,

 

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

 

2022

 

 

2021

 

Research and development

 

$

378

 

 

$

359

 

 

 

$

753

 

 

$

774

 

General and administrative

 

 

599

 

 

 

517

 

 

 

 

1,114

 

 

 

979

 

 

 

$

977

 

 

$

876

 

 

 

$

1,867

 

 

$

1,753

 

 

The following table summarizes equity‑based compensation expense by type of award for the three and six months ended June 30, 2022 and 2021 (in thousands):

 

 

 

Three Months Ended June 30

 

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

 

2022

 

 

2021

 

Stock options

 

$

845

 

 

$

800

 

 

 

$

1,665

 

 

$

1,499

 

Restricted stock awards

 

 

113

 

 

 

62

 

 

 

 

166

 

 

 

234

 

ESPP

 

 

19

 

 

 

14

 

 

 

 

36

 

 

 

20

 

 

 

$

977

 

 

$

876

 

 

 

$

1,867

 

 

$

1,753

 

During the six months ended June 30, 2022, the Company granted 2,889,149 stock options with a weighted average exercise price of $1.84. As of June 30, 2022, there was $6.6 million of unrecognized share-based compensation related to unvested stock option grants which is expected to be recognized over a weighted average period of 2.8 years. The total unrecognized share-based compensation cost will be adjusted for actual forfeitures as they occur.

During the six months ended June 30, 2022, the Company granted 507,260 restricted stock awards with a weighted average grant date fair value per share of $1.97. As of June 30, 2022, there was approximately $1.4 million of unrecognized share-based compensation related to restricted stock awards granted, which is expected to be recognized over a weighted average period of 3.3 years. The total unrecognized share-based compensation cost will be adjusted for actual forfeitures as they occur.

For a full description of the Company’s equity plans, refer to Note 9, Equity-based Compensation and Equity Incentive Plans in the 2021 Annual Report.